Friday, 2 December, 2022

Topic: BioNTech

Pfizer Covid vaccine safe for kids aged 5-11 yrs, shows robust antibody response, trail finds

Pfizer and BioNTech SE said phase 1/2/3 trial initially enrolled up to 4,500 kids between 6 months to 11 years in the US, Finland, Poland & Spain from over 90 clinical trial sites.

Beijing delay in approving Pfizer-BioNTech shot raises questions on China’s vaccination plans

Analysts say Beijing's concern might be that approval of the BioNTech shot could be interpreted as an acknowledgment that local shots are less effective than western ones.

8-10 week gap between Pfizer doses boosts antibodies, UK study says

The study said neutralising antibody levels were twice as high after the 10-week interval as with the three-week span.

BioNTech vaccine creates 10 times higher antibody levels compared to Sinovac: Study in Lancet

Researchers noted that antibody concentrations for BioNTech recipients rose 'substantially' after first dose, but Sinovac recipients showed 'low' level of antibodies after first shot.

Could a simple pill beat Covid-19? Pfizer is giving it a go

Where most antiviral agents target the inflammatory and immune response resulting from Covid, Pfizer’s pill directly targets the virus itself.

Pfizer vaccine shows 100% efficacy in 12-15 year olds, is safe for adolescents, US study finds

Study finds Pfizer-BioNTech vaccine has favourable safety profile in 12-15-year-olds, produces greater immune response than in young adults, is highly effective against Covid-19.

Pfizer-BioNTech Covid vaccine cleared for use on adolescents aged 12-15 in US

A group of advisers to Centers for Disease Control and Prevention will meet Wednesday to make recommendations for administering the vaccine. Kids could begin receiving them Thursday.

Discussions on with Indian govt for expedited approval of Pfizer Covid vaccine, says CEO

Pfizer is aware that access to vaccines is critical. Unfortunately, our vaccine is not registered in India although our application was submitted months ago, the CEO added.

Covid-19 pandemic: France lax in containing cases, Palestine wants vaccines from Israel

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

Pfizer-BioNTech vaccine neutralises Brazilian Covid strain in lab experiments

While the research, performed by University of Texas Medical Branch in Galveston, needs to be validated with real-world data, it offers another reason for optimism.

On Camera


File photo of Kerala Governor Arif Mohammed Khan | ANI

Arif Mohammad Khan vs Kerala govt isn’t a new faceoff. Old cases show Governor wears two hats

Under UGC provisions, a search committee is appointed to find suitable candidates for the V-C post. Governors make their selection from among these names.

51 cow universities, old pension scheme, jobs — what RSS affiliates want from 2023 Budget

Welfare schemes and ‘self-reliance’ figure high on Sangh organisations’ wishlists for finance minister Nirmala Sitharaman ahead of the Budget, which she will present on 1 February.


A soldier with 'Arjun', a black kite trained to down enemy drones, during the Yudh Abhyas exercise being held in Auli, Uttarakhand | Suraj Singh Bisht | ThePrint

It’s a plane, no it’s a bird! Army’s training eagles & falcons to swoop down on hostile drones

The birds are also being trained for surveillance at Remount Veterinary Corps Centre in Meerut, with cameras fitted to their heads to record videos.

A Gujarat gamble: A likely reason Rahul is not giving Modi a fight this assembly election

I'd rather not buy idea that Rahul's holding his fire until 2024. More likely, Congress believes Karnataka offers best chance of winning a Gujarat-sized state if Gujarat is too challenging.